β-arrestin2 stimulates interleukin-17 production and expression of CD4 + T lymphocytes in a murine asthma model

Iranian Journal of Allergy, Asthma and Immunology

Volumn 10, Issue 3, 2011, Pages 171-182

  Liu, Yi ^a   Wang, Gu Yi ^a   Liu, Shao Kun ^a   Yang, Mu Yi ^a   Ma, Li Bing ^a   Li, Keng ^a   Gong, Su Bo ^a   Zhang, Li ^a   Chen, Ping ^a   Xiang, Xu Dong ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

arrestin2; Asthma; CD4 + T lymphocytes; Extracellular signal regulated kinase 1 2; Interleukin 17

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; BETA ARRESTIN 2; INTERLEUKIN 17; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; BIOLOGICAL ACTIVITY; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SPLEEN CELL; WESTERN BLOTTING; WILD TYPE;

ANIMALS; ARRESTINS; ASTHMA; BLOTTING, WESTERN; CD4-POSITIVE T-LYMPHOCYTES; CELL SEPARATION; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HYPERSENSITIVITY; INTERLEUKIN-17; LYMPHOCYTE ACTIVATION; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED BALB C; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; REAL-TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE;

EID: 80053029202     PISSN: 17351502     EISSN: 17355249     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005;6(11):1123-32. (Pubitemid 41541790)
2. Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005;6(11):1133-41. (Pubitemid 41541791)
3. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006;441(7090):235-8.
4. Mangan PR, Harrington LE, O'Quinn DB, Helms WS, Bullard DC, Elson CO, et al. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006; 441(7090):231-4.
5. McGeachy MJ, Cua DJ. Th17 cell differentiation: the long and winding road. Immunity 2008; 28(4):445-53. (Pubitemid 351467042)
6. Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 Cells. Annu Rev Immunol 2009; 27:485-517.
7. Nakae S, Komiyama Y, Nambu A, Sudo K, Iwase M, Homma I, et al. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 2002; 17(3):375-87. (Pubitemid 35279557)
8. Hellings PW, Kasran A, Liu Z, Vandekerckhove P, Wuyts A, Overbergh L, et al. Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma. Am J Respir Cell Mol Biol 2003; 28(1):42-50. (Pubitemid 36017049)
9. Oda N, Canelos PB, Essayan DM, Plunkett BA, Myers AC, Huang SK. Interleukin-17F induces pulmonary neutrophilia and amplifies antigen-induced allergic response. Am J Respir Crit Care Med 2005; 171(1):12-8. (Pubitemid 40051689)
10. Molet S, Hamid Q, Davoine F, Nutku E, Taha R, Page N, et al. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol 2001; 108(3):430-8. (Pubitemid 32881066)
11. Zhao Y, Yang J, Gao YD, Guo W. Th17 immunity in patients with allergic asthma. Int Arch Allergy Immunol 2010; 151(4):297-307.
12. Louis R, Lau LC, Bron AO, Roldaan AC, Radermecker M, Djukanovic R. The relationship between airways inflammation and asthma severity. Am J Respir Crit Care Med 2000; 161(1):9-16. (Pubitemid 30055896)
13. Iwakura Y, Nakae S, Saijo S, Ishigame H. The roles of IL-17A in inflammatory immune responses and host defense against pathogens. Immunol Rev 2008; 226:57-79.
14. McKinley L, Alcorn JF, Peterson A, Dupont RB, Kapadia S, Logar A, et al. TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice. J Immunol 2008; 181(6):4089-97.
15. Reiter E, Lefkowitz RJ. GRKs and beta-arrestins: roles in receptor silencing, trafficking and signaling. Trends Endocrinol Metab 2006; 17(4):159-65.
16. Lefkowitz RJ, Whalen EJ. beta-arrestins: traffic cops of cell signaling. Curr Opin Cell Biol 2004; 16(2):162-8. (Pubitemid 38757292)
17. Lefkowitz RJ, Shenoy SK. Transduction of receptor signals by beta-arrestins. Science 2005; 308(5721):512-7.
18. Jeong HC, Lee SY, Lee EJ, Jung KH, Kang EH, Kim JH, et al. Proteomic analysis of peripheral T-lymphocytes in patients with asthma. Chest 2007; 132(2):489-96. (Pubitemid 47282381)
19. Walker JK, Fong AM, Lawson BL, Savov JD, Patel DD, Schwartz DA, et al. Beta-arrestin-2 regulates the development of allergic asthma. J Clin Invest 2003; 112(4):566-74. (Pubitemid 38056341)
20. Fan H, Luttrell LM, Tempel GE, Senn JJ, Halushka PV, Cook JA. Beta-arrestins 1 and 2 differentially regulate LPS-induced signaling and pro-inflammatory gene expression. Mol Immunol 2007; 44(12):3092-9. (Pubitemid 46610509)
21. Stojanovic I, Cvjeticanin T, Lazaroski S, Stosic-Grujicic S, Miljkovic D. Macrophage migration inhibitory factor stimulates interleukin-17 expression and production in lymph node cells. Immunology 2009; 126(1):74-83.
22. North ML, Khanna N, Marsden PA, Grasemann H, Scott JA. Functionally important role for arginase 1 in the airway hyperresponsiveness of asthma. Am J Physiol Lung Cell Mol Physiol 2009; 296(6):L911-20.
23. Vanoirbeek JA, De Vooght V, Vanhooren HM, Nawrot TS, Nemery B, Hoet PH. How long do the systemic and ventilatory responses to toluene diisocyanate persist in dermally sensitized mice? J Allergy Clin Immunol 2008; 121(2):456-63 e5.
24. Jang BC, Lim KJ, Paik JH, Kwon YK, Shin SW, Kim SC, et al. Up-regulation of human beta-defensin 2 by interleukin-1beta in A549 cells: involvement of PI3K, PKC, p38 MAPK, JNK, and NF-kappaB. Biochem Biophys Res Commun 2004; 320(3):1026-33.
25. Ferrada MA, Gordon EL, Jen KY, He HZ, Lu X, Barone LM, et al. (R)-albuterol decreases immune responses: role of activated T cells. Respir Res 2008; 9:3.
26. Attramadal H, Arriza JL, Aoki C, Dawson TM, Codina J, Kwatra MM, et al. Beta-arrestin2, a novel member of the arrestin/beta-arrestin gene family. J Biol Chem 1992; 267(25):17882-90.
27. Luttrell LM, Roudabush FL, Choy EW, Miller WE, Field ME, Pierce KL, et al. Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds. Proc Natl Acad Sci U S A 2001; 98(5):2449-54. (Pubitemid 32209502)
28. DeFea KA, Vaughn ZD, O'Bryan EM, Nishijima D, Dery O, Bunnett NW. The proliferative and antiapoptotic effects of substance P are facilitated by formation of a beta -arrestin-dependent scaffolding complex. Proc Natl Acad Sci U S A 2000; 97(20):11086-91.
29. DeFea KA, Zalevsky J, Thoma MS, Dery O, Mullins RD, Bunnett NW. Beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2. J Cell Biol 2000; 148(6):1267-81.
30. Yang XO, Panopoulos AD, Nurieva R, Chang SH, Wang D, Watowich SS, et al. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J Biol Chem 2007; 282(13):9358-63. (Pubitemid 47104613)
31. Cho ML, Ju JH, Kim KW, Moon YM, Lee SY, Min SY, et al. Cyclosporine A inhibits IL-15-induced IL-17 production in CD4+ T cells via down-regulation of PI3K/Akt and NF-kappaB. Immunol Lett 2007; 108(1):88-96. (Pubitemid 46001466)
32. Bogoyevitch MA, Boehm I, Oakley A, Ketterman AJ, Barr RK. Targeting the JNK MAPK cascade for inhibition: basic science and therapeutic potential. Biochim Biophys Acta 2004;1697(1-2):89-101. (Pubitemid 38326764)